These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1664857)

  • 41. Separation and quantitation of hydralazine metabolites by high-performance liquid chromatography.
    Lacagnin LB; Colby HD; O'Donnell JP
    J Chromatogr; 1986 Apr; 377():319-27. PubMed ID: 3711222
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enzyme-mediated covalent binding of hydralazine to rat liver microsomes.
    Streeter AJ; Timbrell JA
    Drug Metab Dispos; 1983; 11(3):179-83. PubMed ID: 6135572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolism and disposition of hydralazine-14C in man and dog.
    Lesser JM; Israili ZH; Davis DC; Dayton PG
    Drug Metab Dispos; 1974; 2(4):351-60. PubMed ID: 4153405
    [No Abstract]   [Full Text] [Related]  

  • 44. Myeloperoxidase-based chemiluminescence of polymorphonuclear leukocytes and monocytes.
    McNally JA; Bell AL
    J Biolumin Chemilumin; 1996; 11(2):99-106. PubMed ID: 8726584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lupus-like syndrome in a mother and newborn following administration of hydralazine; a case report.
    Yemini M; Shoham Z; Dgani R; Lancet M; Mogilner BM; Nissim F; Bar-Khayim Y
    Eur J Obstet Gynecol Reprod Biol; 1989 Feb; 30(2):193-7. PubMed ID: 2703104
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of formation and excretion of some metabolites of hydralazine and their hypotensive effect in rats.
    Ogiso T; Iwaki M; Ohtsuki N
    J Pharmacol Exp Ther; 1985 May; 233(2):485-90. PubMed ID: 3999031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils.
    Jiang X; Khursigara G; Rubin RL
    Science; 1994 Nov; 266(5186):810-3. PubMed ID: 7973636
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective high-performance liquid chromatographic assays for hydralazine and its metabolites in plasma of man.
    Reece PA; Cozamanis I; Zacest R
    J Chromatogr; 1980 Mar; 181(3-4):427-40. PubMed ID: 7391156
    [TBL] [Abstract][Full Text] [Related]  

  • 49. N-chlorination of phenytoin by myeloperoxidase to a reactive metabolite.
    Uetrecht J; Zahid N
    Chem Res Toxicol; 1988; 1(3):148-51. PubMed ID: 2856515
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fate of hydralazine in man. II. Formation of tetrazolo[5,1-a]phthalazine in vivo and inhibition of monoamine oxidase by this metabolite.
    Noda A; Noda H; Minemoto M; Zaitsu K; Ohkura Y; Iguchi S
    Chem Pharm Bull (Tokyo); 1981 Sep; 29(9):2683-5. PubMed ID: 7349285
    [No Abstract]   [Full Text] [Related]  

  • 51. Severe renal failure in hydralazine-induced lupus.
    Sinclair AJ; Warrington SJ
    Hum Toxicol; 1981; 1(1):65-9. PubMed ID: 7348694
    [No Abstract]   [Full Text] [Related]  

  • 52. Polymorphic acetylation of hydralazine.
    Timbrell JA; Harland SJ; Facchini V
    Clin Pharmacol Ther; 1980 Sep; 28(3):350-5. PubMed ID: 7408395
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Idiosyncratic drug reactions: possible role of reactive metabolites generated by leukocytes.
    Uetrecht JP
    Pharm Res; 1989 Apr; 6(4):265-73. PubMed ID: 2664753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolism of hydralazine in man.
    Wagner J; Faigle JW; Imhof P; Liehr G
    Arzneimittelforschung; 1977; 27(12):2388-95. PubMed ID: 580056
    [No Abstract]   [Full Text] [Related]  

  • 55. Mechanisms of drug-induced lupus. IV. Comparison of procainamide and hydralazine with analogs in vitro and in vivo.
    Yung R; Chang S; Hemati N; Johnson K; Richardson B
    Arthritis Rheum; 1997 Aug; 40(8):1436-43. PubMed ID: 9259423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Kinetics of hydralazine elimination.
    Talseth T
    Clin Pharmacol Ther; 1977 Jun; 21(6):715-20. PubMed ID: 862310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gas chromatographic method for the simultaneous determination of hydralazine and its acetylated metabolite in serum using a nitrogen-selective detector.
    Angelo HR; Christensen JM
    J Chromatogr; 1980 Aug; 183(2):159-66. PubMed ID: 7400274
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activation of CGS 12094 (prinomide metabolite) to 1,4-benzoquinone by myeloperoxidase: implications for human idiosyncratic agranulocytosis.
    Parrish DD; Schlosser MJ; Kapeghian JC; Traina VM
    Fundam Appl Toxicol; 1997 Feb; 35(2):197-204. PubMed ID: 9038241
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolism of procainamide to a hydroxylamine by human neutrophils and mononuclear leukocytes.
    Uetrecht J; Zahid N; Rubin R
    Chem Res Toxicol; 1988; 1(1):74-8. PubMed ID: 2979715
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug-related lupus.
    Hess EV
    Curr Opin Rheumatol; 1991 Oct; 3(5):809-14. PubMed ID: 1751313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.